ZA986596B - Mammalian cytokine related reagents - Google Patents

Mammalian cytokine related reagents

Info

Publication number
ZA986596B
ZA986596B ZA986596A ZA986596A ZA986596B ZA 986596 B ZA986596 B ZA 986596B ZA 986596 A ZA986596 A ZA 986596A ZA 986596 A ZA986596 A ZA 986596A ZA 986596 B ZA986596 B ZA 986596B
Authority
ZA
South Africa
Prior art keywords
related reagents
mammalian cytokine
cytokine related
mammalian
reagents
Prior art date
Application number
ZA986596A
Other languages
English (en)
Inventor
J Fernando Bazan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25413278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA986596(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA986596B publication Critical patent/ZA986596B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA986596A 1997-07-25 1998-07-23 Mammalian cytokine related reagents ZA986596B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90090597A 1997-07-25 1997-07-25

Publications (1)

Publication Number Publication Date
ZA986596B true ZA986596B (en) 1999-02-08

Family

ID=25413278

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA986596A ZA986596B (en) 1997-07-25 1998-07-23 Mammalian cytokine related reagents

Country Status (28)

Country Link
EP (3) EP2100959B1 (de)
JP (5) JP4316133B2 (de)
KR (1) KR100666835B1 (de)
CN (2) CN101851286A (de)
AR (2) AR017510A1 (de)
AT (1) ATE443142T1 (de)
AU (1) AU741046B2 (de)
BR (1) BR9811039A (de)
CA (1) CA2296272C (de)
CO (1) CO4810232A1 (de)
CZ (1) CZ300958B6 (de)
DE (1) DE69841161D1 (de)
DK (2) DK2100959T3 (de)
ES (2) ES2331762T3 (de)
HU (1) HU230629B1 (de)
ID (1) ID28114A (de)
IL (3) IL134068A0 (de)
LT (1) LT2100959T (de)
MY (1) MY157028A (de)
NO (1) NO329329B1 (de)
NZ (1) NZ502391A (de)
PE (1) PE20000183A1 (de)
PL (1) PL197150B1 (de)
PT (2) PT2100959T (de)
SK (1) SK287198B6 (de)
TW (1) TWI237057B (de)
WO (1) WO1999005280A1 (de)
ZA (1) ZA986596B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060284A (en) 1997-07-25 2000-05-09 Schering Corporation DNA encoding interleukin-B30
US6610515B1 (en) * 1997-10-23 2003-08-26 Nippon Institute For Biological Science Feline granulocyte colony-stimulating factor
AU2661199A (en) * 1998-02-06 1999-08-23 Schering Corporation Mammalian receptor proteins; related reagents and methods
WO1999054357A1 (en) * 1998-04-14 1999-10-28 Chugai Research Institute For Molecular Medicine, Inc. Novel cytokine-like protein
EP1905832A3 (de) 1999-09-09 2009-09-09 Schering Corporation Säuger Interleukin-12 P40 und Interleukin B30, Antikörper, Verwendungen in pharmazeutischen Zusammenstellungen
AU2005202420B2 (en) * 1999-09-09 2008-08-07 Merck Sharp & Dohme Corp. Mammalian cytokines; related reagents and methods
CA2388562C (en) * 1999-09-09 2014-07-22 Schering Corporation Mammalian cytokines; related reagents and methods
US7090847B1 (en) 1999-09-09 2006-08-15 Schering Corporation Mammalian cytokines; related reagents and methods
US7510709B2 (en) 2002-10-30 2009-03-31 Genentech, Inc. Method of treating inflammatory disease by inhibition of IL-17 production
EP1623011B1 (de) 2003-05-09 2013-01-02 Janssen Biotech, Inc. Von il-23p40-spezifischem immunglobulin abgeleitete proteine, zusammensetzungen, verfahren und verwendungen
WO2005108425A1 (en) * 2004-05-10 2005-11-17 Cytos Biotechnology Ag Il-23 p19 antigen array and uses thereof
AR051444A1 (es) 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
AU2006265002B2 (en) 2005-06-30 2012-09-20 Centocor, Inc. Anti-IL-23 antibodies, compositions, methods and uses
SI1971366T1 (sl) 2005-12-29 2014-10-30 Janssen Biotech, Inc. Humana protitelesa anti-il-23, sestavki, postopki in uporabe
US7910703B2 (en) 2006-03-10 2011-03-22 Zymogenetics, Inc. Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
JP2009540018A (ja) 2006-06-13 2009-11-19 ザイモジェネティクス， インコーポレイテッド Ｉｌ−１７およびｉｌ−２３アンタゴニストならびにその使用方法
TWI426918B (zh) 2007-02-12 2014-02-21 Merck Sharp & Dohme Ｉｌ-２３拮抗劑於治療感染之用途
EP2220120A2 (de) 2007-11-27 2010-08-25 Ablynx N.V. Gegen heterodimere cytokine und/oder deren rezeptoren gerichtete aminosäuresequenzen, und polypeptide, die diese enthalten
SG10201608871XA (en) 2008-05-05 2016-12-29 Novimmune Sa Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
CA2759848C (en) 2009-05-05 2018-12-04 Novimmune S.A. Anti-il-17f antibodies and methods of use thereof
JO3244B1 (ar) 2009-10-26 2018-03-08 Amgen Inc بروتينات ربط مستضادات il – 23 البشرية
PE20141162A1 (es) 2010-11-04 2014-09-18 Boehringer Ingelheim Int Anticuerpos anti-il-23
EP4039275A1 (de) 2012-05-03 2022-08-10 Boehringer Ingelheim International GmbH Anti-il-23p19-antikörper
KR20150128859A (ko) 2013-03-15 2015-11-18 암젠 인크 항-il23 항체를 사용하여 크론병을 치료하는 방법
EP2968488A1 (de) 2013-03-15 2016-01-20 Amgen Inc. Verfahren zur behandlung von psoriasis unter verwendung eines anti-il-23-antikörpers
EP3172339A1 (de) 2014-07-24 2017-05-31 Boehringer Ingelheim International GmbH Biomarker zur verwendung bei der behandlung von erkrankungen im zusammenhang mit il-23a
UA123624C2 (uk) 2014-09-03 2021-05-05 Бьорінґер Інґельхайм Інтернаціональ Ґмбх Сполука, специфічна до іл-23а та фнп-альфа, та її застосування
CN107206081A (zh) 2015-02-04 2017-09-26 勃林格殷格翰国际有限公司 治疗炎性疾病的方法
JP6909208B2 (ja) 2015-09-17 2021-07-28 アムジェン インコーポレイテッド Ｉｌ２３経路バイオマーカーを使用するｉｌ２３アンタゴニストに対する臨床応答の予測
AU2016379157A1 (en) 2015-12-22 2018-06-21 Amgen Inc. CCL20 as a predictor of clinical response to IL23-antagonists
CA3105598A1 (en) 2018-07-13 2020-01-16 Carl GOMMOLL Treating ulcerative colitis with brazikumab
MA55149A (fr) 2018-11-20 2021-09-29 Janssen Biotech Inc Procédé sûr et efficace de traitement du psoriasis avec un anticorps spécifique anti-il-23
WO2020234834A1 (en) 2019-05-23 2020-11-26 Janssen Biotech, Inc. Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha
US12577297B2 (en) 2019-09-09 2026-03-17 Boehringer Ingelheim International Gmbh Anti-IL-23p19 antibody formulations
CA3164996A1 (en) 2019-12-20 2021-06-14 Novarock Biotherapeutics, Ltd. Anti-interleukin-23 p19 antibodies and methods of use thereof
KR20230023663A (ko) 2020-05-21 2023-02-17 얀센 바이오테크 인코포레이티드 Il-23 및 tnf 알파에 대한 항체의 병용 요법으로 염증성 장질환을 치료하는 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2031216A1 (de) 1969-06-19 1971-01-14 Citizen Watch Co Ltd , Tokio Tag und Datum Stellvorrichtung fur Uhren mit Kalender
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
DE3382317D1 (de) 1982-03-15 1991-07-25 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5891680A (en) * 1995-02-08 1999-04-06 Whitehead Institute For Biomedical Research Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
WO1999054357A1 (en) * 1998-04-14 1999-10-28 Chugai Research Institute For Molecular Medicine, Inc. Novel cytokine-like protein

Also Published As

Publication number Publication date
EP2100959B1 (de) 2016-12-07
HK1024932A1 (en) 2000-10-27
IL205765A0 (en) 2011-07-31
CZ300958B6 (cs) 2009-09-23
PT1002084E (pt) 2009-12-16
PE20000183A1 (es) 2000-03-11
KR20010022214A (ko) 2001-03-15
HU230629B1 (hu) 2017-04-28
PL338262A1 (en) 2000-10-09
PT2100959T (pt) 2017-01-09
CN1271387A (zh) 2000-10-25
NO20000343L (no) 2000-03-24
ES2331762T3 (es) 2010-01-14
JP4316133B2 (ja) 2009-08-19
AU741046B2 (en) 2001-11-22
ATE443142T1 (de) 2009-10-15
DE69841161D1 (de) 2009-10-29
MY157028A (en) 2016-04-15
CN101851286A (zh) 2010-10-06
CA2296272A1 (en) 1999-02-04
AU8589498A (en) 1999-02-16
JP2010011863A (ja) 2010-01-21
EP2100959A2 (de) 2009-09-16
PL197150B1 (pl) 2008-03-31
EP2100959A3 (de) 2009-10-14
EP1002084B1 (de) 2009-09-16
EP2233574A1 (de) 2010-09-29
JP2015037405A (ja) 2015-02-26
DK2100959T3 (en) 2017-01-30
CO4810232A1 (es) 1999-06-30
CZ2000263A3 (cs) 2000-06-14
SK287198B6 (sk) 2010-03-08
LT2100959T (lt) 2017-01-10
JP2013034480A (ja) 2013-02-21
SK912000A3 (en) 2000-09-12
HUP0004019A3 (en) 2003-08-28
TWI237057B (en) 2005-08-01
JP2005323610A (ja) 2005-11-24
NO20000343D0 (no) 2000-01-24
BR9811039A (pt) 2000-08-08
WO1999005280A1 (en) 1999-02-04
ID28114A (id) 2001-05-03
EP1002084A1 (de) 2000-05-24
AR017510A1 (es) 2001-09-12
IL134068A0 (en) 2001-04-30
CA2296272C (en) 2012-03-13
IL205765A (en) 2015-07-30
HUP0004019A2 (en) 2001-03-28
IL134068A (en) 2010-11-30
AR086483A2 (es) 2013-12-18
JP2001511347A (ja) 2001-08-14
NZ502391A (en) 2002-12-20
KR100666835B1 (ko) 2007-01-11
ES2610483T3 (es) 2017-04-27
NO329329B1 (no) 2010-09-27
DK1002084T3 (da) 2010-01-04

Similar Documents

Publication Publication Date Title
ZA986596B (en) Mammalian cytokine related reagents
HUP0100436A3 (en) Mammalian cytokine-like polypeptide-10
AU7103198A (en) Mammalian cytokines; related reagents and methods
IL148300A0 (en) Mammalian cytokines; related reagents and methods
GB9719044D0 (en) Assay
HUP0002986A3 (en) Fermenter
AU3574997A (en) Mammalian chemokine reagents
GB9715034D0 (en) Assay
IL133582A0 (en) Mammalian neuro-growth factor like protein
AU7276098A (en) Mammalian cytokine-like receptor
GB9701710D0 (en) Mammalian protein
GB9715522D0 (en) Assays
IL143052A0 (en) Mammalian chondromodulin-like protein
GB9721240D0 (en) Assay
GB2329925B (en) Panel support member
ZA989343B (en) Mammalian cytokines; related reagents.
PL340723A1 (en) Structural member
GB9701050D0 (en) Structural member
GB9727277D0 (en) Assay
AU6762398A (en) Mammalian cytokine receptor
GB9719428D0 (en) Assay
IL133715A0 (en) Mammalian secretory peptide-9
ZA985390B (en) Mammalian genes; related reagents
PL322145A1 (en) Shaped structural member
AU4133497A (en) Mammalian cytokine, related reagents